
NU Priga M 1500mcg/75mg Tablet SR
Marketer
Kiama Lifesciences
Salt Composition
Methylcobalamin (1500mcg) + Pregabalin (75mg)
Overview NU Priga M 1500mcg/75mg Tablet SR
Gabapentin enacarbil 1500mcg/75mg extended-release tablets are prescribed for managing neuropathic pain. This medication works by altering nerve cell calcium channel function, reducing pain signals. It also offers neuroprotective benefits, aiding in the repair of damaged nerve cells. Take this medication orally, with or without food, ideally before sleep, at the same time daily for consistent blood levels. Follow your doctor's prescribed dosage and duration; this medication can be habit-forming. If a dose is missed, take it immediately upon recall. Complete the entire course of treatment, even with symptom improvement. Abrupt cessation should be avoided without consulting your physician. Common side effects include upper respiratory infection, increased hunger, elevated mood, shaking, vision blurring, dry mouth, lightheadedness, and drowsiness. Avoid driving or tasks requiring concentration until the medication's effects are known. Side effects generally subside over time. Weight gain is possible; regular exercise and a healthy diet can help mitigate this. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your doctor immediately. Disclose all other medications you're using, as interactions can reduce efficacy or alter the drug's action. Inform your doctor of pregnancy, pregnancy plans, or breastfeeding.
Uses of NU Priga M 1500mcg/75mg Tablet SR
Managing neuropathic pain
Major Benefits of NU Priga M 1500mcg/75mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. NU Priga M 1500mcg/75mg Extended-Release Tablet can be consumed with or without food, though consistent daily timing is recommended.
Common Side effects of NU Priga M 1500mcg/75mg Tablet SR:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use NU Priga M 1500mcg/75mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. NU Priga M 1500mcg/75mg Sustained-Release Tablet can be consumed with or without food, however, consistent daily timing is recommended.
How NU Priga M 1500mcg/75mg Tablet SR works:
NU Priga M 1500mcg/75mg Extended-Release Tablets contain methylcobalamin and pregabalin. Methylcobalamin, a vitamin B12 derivative, supports myelin sheath formation, protecting and repairing nerve cells. Pregabalin, acting as an alpha-2-delta ligand, reduces pain signals by modulating nerve cell calcium channels. This dual action provides relief from neuropathic pain originating in damaged nerves.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of NU Priga M 1500mcg/75mg extended-release tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The extended-release NU Priga M 1500mcg/75mg tablet's safety during pregnancy is uncertain. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release combination of 1500mcg/75mg NU Priga M tablet is likely unsafe for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking NU Priga M 1500mcg/75mg Extended-Release tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use NU Priga M 1500mcg/75mg Extended-Release Tablets cautiously. Dosage modification of NU Priga M 1500mcg/75mg Extended-Release Tablets may be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
Use of NU Priga M 1500mcg/75mg Tablet SR in patients with liver disease appears to present a low risk. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take NU Priga M 1500mcg/75mg Tablet SR :
Should you forget to take a NU Priga M 1500mcg/75mg sustained-release tablet, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About NU Priga M 1500mcg/75mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
